SB2737 - FREED of Opioids Act FDA Review of Efficacy of EERW Double-Blinds of Opioids Act
US Congress - 118th Congress
Introduced byJoe Manchin, Mike Braun
Last updated about 1 year ago
2 Co-Sponsors
A bill to require the Food and Drug Administration to determine whether to permit the use of enriched enrollment randomized withdrawal methodology with respect to clinical trials.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now